Literature DB >> 21350842

Replication of 13 genome-wide association (GWA)-validated risk variants for type 2 diabetes in Pakistani populations.

S D Rees1, M Z I Hydrie, A S Shera, S Kumar, J P O'Hare, A H Barnett, A Basit, M A Kelly.   

Abstract

AIMS/HYPOTHESIS: Recent genome-wide association (GWA) studies and subsequent replication studies have greatly increased the number of validated type 2 diabetes susceptibility variants, but most of these have been conducted in European populations. Despite the high prevalence of the disease in South Asians, studies investigating GWA-validated type 2 diabetes risk variants in this ethnic group are limited. We investigated 30 single nucleotide polymorphisms (SNPs), predominantly derived from recent GWA studies, to determine if and to what extent these variants affect type 2 diabetes risk in two Punjabi populations, originating predominantly from the District of Mirpur, Pakistan.
METHODS: Thirty SNPs were genotyped in 1,678 participants with type 2 diabetes and 1,584 normoglycaemic control participants from two populations; one resident in the UK and one indigenous to the District of Mirpur.
RESULTS: SNPs in or near PPARG, TCF7L2, FTO, CDKN2A/2B, HHEX/IDE, IGF2BP2, SLC30A8, KCNQ1, JAZF1, IRS1, KLF14, CHCHD9 and DUSP9 displayed significant (p < 0.05) associations with type 2 diabetes, with similar effect sizes to those seen in European populations. A constructed genetic risk score was associated with type 2 diabetes (p = 5.46 × 10(-12)), BMI (p = 2.25 × 10(-4)) and age at onset of diabetes (p = 0.002). CONCLUSIONS/
INTERPRETATION: We have demonstrated that 13 variants confer an increased risk of type 2 diabetes in our Pakistani populations; to our knowledge this is the first time that SNPs in or near KCNQ1, JAZF1, IRS1, KLF14, CHCHD9 and DUSP9 have been significantly associated with the disease in South Asians. Large-scale studies and meta-analyses of South Asian populations are needed to further confirm the effect of these variants in this ethnic group.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21350842     DOI: 10.1007/s00125-011-2063-2

Source DB:  PubMed          Journal:  Diabetologia        ISSN: 0012-186X            Impact factor:   10.122


  22 in total

1.  Genetic Power Calculator: design of linkage and association genetic mapping studies of complex traits.

Authors:  S Purcell; S S Cherny; P C Sham
Journal:  Bioinformatics       Date:  2003-01       Impact factor: 6.937

2.  Variant of transcription factor 7-like 2 (TCF7L2) gene confers risk of type 2 diabetes.

Authors:  Struan F A Grant; Gudmar Thorleifsson; Inga Reynisdottir; Rafn Benediktsson; Andrei Manolescu; Jesus Sainz; Agnar Helgason; Hreinn Stefansson; Valur Emilsson; Anna Helgadottir; Unnur Styrkarsdottir; Kristinn P Magnusson; G Bragi Walters; Ebba Palsdottir; Thorbjorg Jonsdottir; Thorunn Gudmundsdottir; Arnaldur Gylfason; Jona Saemundsdottir; Robert L Wilensky; Muredach P Reilly; Daniel J Rader; Yu Bagger; Claus Christiansen; Vilmundur Gudnason; Gunnar Sigurdsson; Unnur Thorsteinsdottir; Jeffrey R Gulcher; Augustine Kong; Kari Stefansson
Journal:  Nat Genet       Date:  2006-01-15       Impact factor: 38.330

3.  Replication of recently described type 2 diabetes gene variants in a South Indian population.

Authors:  Manickam Chidambaram; Venkatesan Radha; Viswanathan Mohan
Journal:  Metabolism       Date:  2010-07-02       Impact factor: 8.694

4.  Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation.

Authors:  K G Alberti; P Z Zimmet
Journal:  Diabet Med       Date:  1998-07       Impact factor: 4.359

5.  Testing the association of novel meta-analysis-derived diabetes risk genes with type II diabetes and related metabolic traits in Asian Indian Sikhs.

Authors:  Dharambir K Sanghera; Latonya Been; Lyda Ortega; Gurpreet S Wander; Narinder K Mehra; Christopher E Aston; John J Mulvihill; Sarju Ralhan
Journal:  J Hum Genet       Date:  2009-02-27       Impact factor: 3.172

Review 6.  From genetic association to molecular mechanism.

Authors:  Martijn van de Bunt; Anna L Gloyn
Journal:  Curr Diab Rep       Date:  2010-12       Impact factor: 4.810

7.  A common variant in the FTO gene is associated with body mass index and predisposes to childhood and adult obesity.

Authors:  Timothy M Frayling; Nicholas J Timpson; Michael N Weedon; Eleftheria Zeggini; Rachel M Freathy; Cecilia M Lindgren; John R B Perry; Katherine S Elliott; Hana Lango; Nigel W Rayner; Beverley Shields; Lorna W Harries; Jeffrey C Barrett; Sian Ellard; Christopher J Groves; Bridget Knight; Ann-Marie Patch; Andrew R Ness; Shah Ebrahim; Debbie A Lawlor; Susan M Ring; Yoav Ben-Shlomo; Marjo-Riitta Jarvelin; Ulla Sovio; Amanda J Bennett; David Melzer; Luigi Ferrucci; Ruth J F Loos; Inês Barroso; Nicholas J Wareham; Fredrik Karpe; Katharine R Owen; Lon R Cardon; Mark Walker; Graham A Hitman; Colin N A Palmer; Alex S F Doney; Andrew D Morris; George Davey Smith; Andrew T Hattersley; Mark I McCarthy
Journal:  Science       Date:  2007-04-12       Impact factor: 47.728

8.  Replication of genome-wide association signals in UK samples reveals risk loci for type 2 diabetes.

Authors:  Eleftheria Zeggini; Michael N Weedon; Cecilia M Lindgren; Timothy M Frayling; Katherine S Elliott; Hana Lango; Nicholas J Timpson; John R B Perry; Nigel W Rayner; Rachel M Freathy; Jeffrey C Barrett; Beverley Shields; Andrew P Morris; Sian Ellard; Christopher J Groves; Lorna W Harries; Jonathan L Marchini; Katharine R Owen; Beatrice Knight; Lon R Cardon; Mark Walker; Graham A Hitman; Andrew D Morris; Alex S F Doney; Mark I McCarthy; Andrew T Hattersley
Journal:  Science       Date:  2007-04-26       Impact factor: 47.728

9.  Combining information from common type 2 diabetes risk polymorphisms improves disease prediction.

Authors:  Michael N Weedon; Mark I McCarthy; Graham Hitman; Mark Walker; Christopher J Groves; Eleftheria Zeggini; N William Rayner; Beverley Shields; Katharine R Owen; Andrew T Hattersley; Timothy M Frayling
Journal:  PLoS Med       Date:  2006-10       Impact factor: 11.069

10.  Impact of nine common type 2 diabetes risk polymorphisms in Asian Indian Sikhs: PPARG2 (Pro12Ala), IGF2BP2, TCF7L2 and FTO variants confer a significant risk.

Authors:  Dharambir K Sanghera; Lyda Ortega; Shizhong Han; Jairup Singh; Sarju K Ralhan; Gurpreet S Wander; Narinder K Mehra; John J Mulvihill; Robert E Ferrell; Swapan K Nath; Mohammed I Kamboh
Journal:  BMC Med Genet       Date:  2008-07-03       Impact factor: 2.103

View more
  47 in total

Review 1.  Type 2 diabetes and gut microbiome: at the intersection of known and unknown.

Authors:  Smitha Upadhyaya; Gautam Banerjee
Journal:  Gut Microbes       Date:  2015

2.  The Uyghur population and genetic susceptibility to type 2 diabetes: potential role for variants in CDKAL1, JAZF1, and IGF1 genes.

Authors:  Manshu Song; Feifei Zhao; Longjin Ran; Mamatyusupu Dolikun; Lijuan Wu; Siqi Ge; Hao Dong; Qing Gao; Yanchun Zhai; Ling Zhang; Yuxiang Yan; Fen Liu; Xinghua Yang; Xiuhua Guo; Youxin Wang; Wei Wang
Journal:  OMICS       Date:  2015-03-18

Review 3.  The Krüppel-Like Factors and Control of Energy Homeostasis.

Authors:  Paishiun N Hsieh; Liyan Fan; David R Sweet; Mukesh K Jain
Journal:  Endocr Rev       Date:  2019-02-01       Impact factor: 19.871

4.  Does genetic heterogeneity account for the divergent risk of type 2 diabetes in South Asian and white European populations?

Authors:  Zahra N Sohani; Wei Q Deng; Guillaume Pare; David Meyre; Hertzel C Gerstein; Sonia S Anand
Journal:  Diabetologia       Date:  2014-08-22       Impact factor: 10.122

Review 5.  Islet biology, the CDKN2A/B locus and type 2 diabetes risk.

Authors:  Yahui Kong; Rohit B Sharma; Benjamin U Nwosu; Laura C Alonso
Journal:  Diabetologia       Date:  2016-05-07       Impact factor: 10.122

6.  Linking Alzheimer's disease and type 2 diabetes: Novel shared susceptibility genes detected by cFDR approach.

Authors:  Xia-Fang Wang; Xu Lin; Ding-You Li; Rou Zhou; Jonathan Greenbaum; Yuan-Cheng Chen; Chun-Ping Zeng; Lin-Ping Peng; Ke-Hao Wu; Zeng-Xin Ao; Jun-Min Lu; Yan-Fang Guo; Jie Shen; Hong-Wen Deng
Journal:  J Neurol Sci       Date:  2017-08-01       Impact factor: 3.181

7.  The KLF14 Variant is Associated with Type 2 Diabetes and HbA1C Level.

Authors:  Ensieh Shahvazian; Mohammad Bagher Mahmoudi; Ehsan Farashahi Yazd; Saba Gharibi; Bahram Moghimi; Pouria HosseinNia; Masoud Mirzaei
Journal:  Biochem Genet       Date:  2021-01-03       Impact factor: 1.890

8.  Meta-analysis of the effect of KCNQ1 gene polymorphism on the risk of type 2 diabetes.

Authors:  Jun Liu; Fang Wang; Yueyue Wu; Xinmei Huang; Li Sheng; Jiong Xu; Bingbing Zha; Heyuan Ding; Zaoping Chen; Tiange Sun
Journal:  Mol Biol Rep       Date:  2012-12-28       Impact factor: 2.316

Review 9.  Long noncoding RNA variations in cardiometabolic diseases.

Authors:  Sariya Dechamethakun; Masaaki Muramatsu
Journal:  J Hum Genet       Date:  2016-06-16       Impact factor: 3.172

10.  Perhexiline activates KLF14 and reduces atherosclerosis by modulating ApoA-I production.

Authors:  Yanhong Guo; Yanbo Fan; Jifeng Zhang; Gwen A Lomberk; Zhou Zhou; Lijie Sun; Angela J Mathison; Minerva T Garcia-Barrio; Ji Zhang; Lixia Zeng; Lei Li; Subramaniam Pennathur; Cristen J Willer; Daniel J Rader; Raul Urrutia; Y Eugene Chen
Journal:  J Clin Invest       Date:  2015-09-14       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.